This HTML5 document contains 94 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37424837
rdf:type
wikibase:Item
schema:description
articolo scientifico article scientifique наукова стаття, опублікована в липні 2011 videnskabelig artikel vědecký článek научни чланак artigo científico artículu científicu espublizáu en 2011 wissenschaftlicher Artikel article científic scientific article published on 07 July 2011 مقالة علمية نشرت في 07 يوليو 2011 wetenschappelijk artikel vetenskaplig artikel bilimsel makale vedecký článok
p:P577
wds:Q37424837-070283A5-5C14-4396-BE0F-B9A2C1FBAFFE
wdt:P577
2011-07-07T00:00:00Z
p:P407
wds:Q37424837-0078D221-3FCB-49F6-9F0F-2C9DA4C2D591
wdt:P407
wd:Q1860
p:P2860
wds:Q37424837-11D3DFB8-8535-4B65-B7C9-30F337C137C1 wds:Q37424837-1DFFE43B-1580-42EF-A955-F33639B61046 wds:Q37424837-38B06F31-0127-46F5-AF6C-CF4F58A3015F wds:Q37424837-A8F37863-E6E4-412E-8EA5-BDDA420BD1C2 wds:Q37424837-AD5B43F0-2927-4FE8-9988-3BA62AD46B6D wds:Q37424837-D0742D75-B8A8-4642-B511-AF1CA5FA675C wds:Q37424837-498BF0F8-08DC-488E-A0EA-C448927E9B0D wds:Q37424837-71D8CC11-39A6-4C9B-B64A-131310D637DC wds:Q37424837-8E86017E-E27E-41A5-8F0B-5A3B8EE14CAB wds:Q37424837-E17E57F7-9FAE-43A0-BC22-B66EBFCC7571
wdt:P2860
wd:Q39934166 wd:Q40721082 wd:Q39425063 wd:Q73769171 wd:Q50649768 wd:Q68991842 wd:Q47634660 wd:Q38357543 wd:Q40622703 wd:Q69937752
p:P2093
wds:Q37424837-F0A14B62-48A1-4281-8B2C-E0C84453FFBA wds:Q37424837-E8A399B9-867E-4B2F-B947-129E9FDB8304 wds:Q37424837-E08D0A09-C5F2-4293-AE46-351F14E54A8D wds:Q37424837-BD315767-8838-4C99-B616-7719E2EF7E8A wds:Q37424837-9854D751-8E5F-4A53-802E-FE16B2B73FFB wds:Q37424837-9D80BEA3-0B65-4E70-B7B6-FD6605E50195 wds:Q37424837-80B9F82F-575E-412E-A49E-8E1C23401F0C
wdt:P2093
Yumin Shen Srikanth Gajavelli Stefan Barta Ira Braunchweig Samir Parekh Amit Verma John Schindler
rdfs:label
A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins
skos:prefLabel
A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia
schema:name
A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins
p:P50
wds:Q37424837-EAFB6424-CA98-49C0-980B-49010B54E911 wds:Q37424837-7B14F58B-921C-4A09-A940-C224F12DAA13 wds:Q37424837-728D187C-C1EE-41C7-9BCA-61E38B1D642A
wdt:P50
wd:Q4795310 wd:Q114435176 wd:Q40614280
p:P1476
wds:Q37424837-67CC99CD-89B6-45CD-934E-6FD99ACDBCF5
wdt:P1476
A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia
p:P304
wds:Q37424837-F6624920-4826-40A4-A50A-1F430AFD2915
wdt:P304
471-476
p:P31
wds:Q37424837-09C771FC-3CD3-485A-94AA-457BB0B3EC0C
wdt:P31
wd:Q13442814
p:P921
wds:Q37424837-490225DC-006D-4920-917A-1DAD490EF095
wdt:P921
wd:Q29496
p:P698
wds:Q37424837-FC7DF4A3-FD3D-4B80-9167-418FE4FEBEFB
wdtn:P698
n12:21732928
wdt:P698
21732928
p:P1433
wds:Q37424837-0C213108-7A21-42E8-9401-7DCF136C9822
wdt:P1433
wd:Q4970200
p:P433
wds:Q37424837-E7E83892-9D12-4C51-8D92-7E25AD79B8F5
p:P478
wds:Q37424837-BEEB283D-B8CC-4313-AAB6-BF317C67FCF9
wdt:P433
4
wdt:P478
154
p:P356
wds:Q37424837-E89A89BA-452B-49CF-A985-91A84767DF2C
wdtn:P356
n8:J.1365-2141.2011.08762.X
wdt:P356
10.1111/J.1365-2141.2011.08762.X
p:P5875
wds:Q37424837-73637386-6CA0-4861-87CD-331B4588301B
wdt:P5875
51470911
p:P932
wds:Q37424837-B1F0168C-B06C-4624-AFF8-E5AC1266C26B
wdt:P932
3877839